The enzyme can be inhibited by aldose reductase inhibitors.
Specific reactions catalyzed by this enzyme include:
Role in diabetes
Glucose concentrations are often elevated in diabetics and aldose reductase has long been believed to be responsible for diabetic complications involving a number of organs. Many aldose reductase inhibitors have been developed as drug candidates but virtually all have failed although some are commercially available in several countries.
The aldose reductase reaction, in particular the sorbitol produced, is important for the function of various organs in the body. For example, it is generally used as the first step in a synthesis of fructose from glucose; the second step is the oxidation of sorbitol to fructose catalyzed by sorbitol dehydrogenase. The main pathway from glucose to fructose (glycolysis) involves phosphorylation of glucose by hexokinase to form glucose 6-phosphate, followed by isomerization to fructose 6-phosphate and hydrolysis of the phosphate, but the sorbitol pathway is useful because it does not require the input of energy in the form of ATP:
- Seminal vesicles: Fructose produced from sorbitol is used by the sperm cells.
- Liver: Fructose produced from sorbitol can be used as an energy source for glycolysis and glyconeogenesis.
- Denise R., PhD. Ferrier (2005). Lippincott's Illustrated Reviews: Biochemistry (Lippincott's Illustrated Reviews). Hagerstwon, MD: Lippincott Williams & Wilkins. p. 319. ISBN 0-7817-2265-9.
- IUBMB entry for 18.104.22.168
- BRENDA references for 22.214.171.124 (Recommended.)
- PubMed references for 126.96.36.199
- PubMed Central references for 188.8.131.52
- Google Scholar references for 184.108.40.206
- AKR1A1, AKR1B1
|This EC 1.1.1 enzyme-related article is a stub. You can help Wikipedia by expanding it.|